器官移植病理学临床技术操作规范(2019版)——总论与肾移植
|
摘要
为了进一步规范器官移植病理学临床技术操作,中华医学会器官移植学分会组织器官移植专家和移植病理学专家,从移植病理学诊断的基本内容、基本原则、基本方法等方面,制定器官移植病理学临床技术操作规范(2019版)之移植病理学诊断的基本规范;从尸体供肾病理学评估、移植肾活组织检查(活检)病理学临床技术操作规范、移植肾活检病理学诊断临床技术操作规范、移植肾活检电镜诊断临床技术操作规范等方面,制定器官移植病理学临床技术操作规范(2019版)之移植肾脏病理学临床技术操作规范。
引文
[1]陈实,郭晖.移植病理学[M].北京:人民卫生出版社,2009.
[2]朱有华,曾力.肾移植[M].北京:人民卫生出版社,2017.
[3]中华医学会器官移植学分会,中华医学会外科学分会移植学组,中国医师协会器官移植医师分会.中国心脏死亡捐献器官评估与应用专家共识[J/CD].中华移植杂志(电子版),2014,8(3):117-122.DOI:10.3877/cma.j.issn.1647-3903.2014.03.001.Branch of Organ Transplantation of Chinese Medical Association,Division of Transplantation of Branch of Surgery of Chinese Medical Association,Branch of Organ Transplant Physician of Chinese Medical Doctor Association.Expert consensus on evaluation and application of organ donated after cardiac death in China[J/CD].Chin J Transplant(Electr Vers),2014,8(3):117-122.DOI:10.3877/cma.j.issn.1647-3903.2014.03.001.
[4]中华医学会器官移植学分会.中国心脏死亡器官捐献工作指南(第2版)[J].中华器官移植杂志,2011,32(12):756-758.DOI:10.3760/cma.j.issn.0254-1785.2011.12.014.Branch of Organ Transplantation of Chinese Medical Association.Work guideline of donation after cardiac death in China(2nd edition)[J].Chin J Organ Transplant,2011,32(12):756-758.DOI:10.3760/cma.j.issn.0254-1785.2011.12.014.
[5]中华医学会器官移植学分会,中国医师协会器官移植医师分会.中国公民逝世后器官捐献供肾体外低温机械灌注保存专家共识(2016版)[J/CD].中华移植杂志(电子版),2016,10(4):154-158.DOI:10.3877/cma.j.issn.1674-3903.2016.04.002.Branch of Organ Transplantation of Chinese Medical Association,Branch of Organ Transplant Physician of Chinese Medical Doctor Association.Expert consensus on donor kidney in external hypothermic machine perfusion preservation of Chinese donation after citizen's death(2016 edition)[J/CD].Chin J Transplant(Electr Vers),2016,10(4):154-158.DOI:10.3877/cma.j.issn.1674-3903.2016.04.002.
[6]郭晖,陈知水,陈实.公民逝世后器官捐献供肾的病理学评估[J].器官移植,2018,9(1):1-8.DOI:10.3969/j.issn.1674-7445.2018.01.001.GUO H,CHEN ZS,CHEN S.Pathological evaluation of donor kidney in donation after citizen's death[J].Organ Transplant,2018,9(1):1-8.DOI:10.3969/j.issn.1674-7445.2018.01.001.
[7]郭晖.对DCD供肾病理学评估研究的思考[J/CD].实用器官移植电子杂志,2017,5(6):417-424.DOI:10.3969/j.issn.2095-5332.2017.06.004.GUO H.Reflections on the pathology evaluation study of donor kidney nephrology of DCD[J/CD].Pract J Organ Transplant(Electr Vers),2017,5(6):417-424.DOI:10.3969/j.issn.2095-5332.2017.06.004.
[8]HAAS M.Donor kidney biopsies:pathology matters,and so does the pathologist[J].Kidney Int,2014,85(5):1016-1019.DOI:10.1038/ki.2013.439.
[9]GOUMENOS DS,KALLIAKMANI P,TSAMANDASAC,et al.The prognostic value of frozen section preimplantation graft biopsy in the outcome of renal transplantation[J].Ren Fail,2010,32(4):434-439.DOI:10.3109/08860221003658241.
[10]RANDHAWA P.Role of donor kidney biopsies in renal transplantation[J].Transplantation,2001,71(10):1361-1365.
[11]RANDHAWA PS,MINERVINI MI,LOMBARDERO M,et al.Biopsy of marginal donor kidneys:correlation of histologic findings with graft dysfunction[J].Transplantation,2000,69(7):1352-1357.
[12]REMUZZI G,GRINYòJ,RUGGENENTI P,et al.Early experience with dual kidney transplantation in adults using expanded donor criteria.Double Kidney Transplant Group(DKG)[J].J Am Soc Nephrol,1999,10(12):2591-2598.
[13]ISONIEMI H,TASKINEN E,H?YRY P.Histological chronic allograft damage index accurately predicts chronic renal allograft rejection[J].Transplantation,1994,58(11):1195-1198.
[14]KARPINSKI J,LAJOIE G,CATTRAN D,et al.Outcome of kidney transplantation from high-risk donors is determined by both structure and function[J].Transplantation,1999,67(8):1162-1167.
[15]MUNIVENKATAPPA RB,SCHWEITZER EJ,PAPADIMITRIOUJC,et al.The Maryland aggregate pathology index:a deceased donor kidney biopsy scoring system for predicting graft failure[J].Am J Transplant,2008,8(11):2316-2324.DOI:10.1111/j.1600-6143.2008.02370.x.
[16]FLECHNER SM,CAMPBELL SC.The use of kidneys with small renal tumors for transplantation:who is taking the risk?[J].Am J Transplant,2012,12(1):48-54.DOI:10.1111/j.1600-6143.2011.03794.x.
[17]HAAS M,LOUPY A,LEFAUCHEUR C,et al.The Banff 2017 Kidney Meeting report:revised diagnostic criteria for chronic active T cell-mediated rejection,antibody-mediated rejection,and prospects for integrative endpoints for next-generation clinical trials[J].Am JTransplant,2018,18(2):293-307.DOI:10.1111/ajt.14625.
[18]HUANG G,WU LW,YANG SC,et al.Factors influencing graft outcomes following diagnosis of polyomavirus-associated nephropathy after renal transplantation[J].PLo S One,2015,10(11):e0142460.DOI:10.1371/journal.pone.0142460.
[19]HUANG G,CHEN LZ,QIU J,et al.Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China:a single-center analysis of incidence,reduction in immunosuppression and clinical course[J].Clin Transplant,2010,24(5):599-609.DOI:10.1111/j.1399-0012.2009.01141.x.
[20]KOTTON CN,KUMAR D,CALIENDO AM,et al.The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J].Transplantation,2018,102(6):900-931.DOI:10.1097/TP.0000000000002191.
[21]TILLOU X,GULERYUZ K,COLLON S,et al.Renal cell carcinoma in functional renal graft:toward ablative treatments[J].Transplant Rev(Orlando),2016,30(1):20-26.DOI:10.1016/j.trre.2015.07.001.
[22]SCOTT MH,SELLS RA.Primary adenocarcinoma in a transplanted cadaveric kidney[J].Transplantation,1988,46(1):157-158.
[23]TILLOU X,DOERFLER A,COLLON S,et al.De novo kidney graft tumors:results from a multicentric retrospective national study[J].Am J Transplant,2012,12(12):3308-3315.DOI:10.1111/j.1600-6143.2012.04248.x.
[24]NALESNIK MA,WOODLE ES,DIMAIO JM,et al.Donor-transmitted malignancies in organ transplantation:assessment of clinical risk[J].Am J Transplant,2011,11(6):1140-1147.DOI:10.1111/j.1600-6143.2011.03565.x.
[2]朱有华,曾力.肾移植[M].北京:人民卫生出版社,2017.
[3]中华医学会器官移植学分会,中华医学会外科学分会移植学组,中国医师协会器官移植医师分会.中国心脏死亡捐献器官评估与应用专家共识[J/CD].中华移植杂志(电子版),2014,8(3):117-122.DOI:10.3877/cma.j.issn.1647-3903.2014.03.001.Branch of Organ Transplantation of Chinese Medical Association,Division of Transplantation of Branch of Surgery of Chinese Medical Association,Branch of Organ Transplant Physician of Chinese Medical Doctor Association.Expert consensus on evaluation and application of organ donated after cardiac death in China[J/CD].Chin J Transplant(Electr Vers),2014,8(3):117-122.DOI:10.3877/cma.j.issn.1647-3903.2014.03.001.
[4]中华医学会器官移植学分会.中国心脏死亡器官捐献工作指南(第2版)[J].中华器官移植杂志,2011,32(12):756-758.DOI:10.3760/cma.j.issn.0254-1785.2011.12.014.Branch of Organ Transplantation of Chinese Medical Association.Work guideline of donation after cardiac death in China(2nd edition)[J].Chin J Organ Transplant,2011,32(12):756-758.DOI:10.3760/cma.j.issn.0254-1785.2011.12.014.
[5]中华医学会器官移植学分会,中国医师协会器官移植医师分会.中国公民逝世后器官捐献供肾体外低温机械灌注保存专家共识(2016版)[J/CD].中华移植杂志(电子版),2016,10(4):154-158.DOI:10.3877/cma.j.issn.1674-3903.2016.04.002.Branch of Organ Transplantation of Chinese Medical Association,Branch of Organ Transplant Physician of Chinese Medical Doctor Association.Expert consensus on donor kidney in external hypothermic machine perfusion preservation of Chinese donation after citizen's death(2016 edition)[J/CD].Chin J Transplant(Electr Vers),2016,10(4):154-158.DOI:10.3877/cma.j.issn.1674-3903.2016.04.002.
[6]郭晖,陈知水,陈实.公民逝世后器官捐献供肾的病理学评估[J].器官移植,2018,9(1):1-8.DOI:10.3969/j.issn.1674-7445.2018.01.001.GUO H,CHEN ZS,CHEN S.Pathological evaluation of donor kidney in donation after citizen's death[J].Organ Transplant,2018,9(1):1-8.DOI:10.3969/j.issn.1674-7445.2018.01.001.
[7]郭晖.对DCD供肾病理学评估研究的思考[J/CD].实用器官移植电子杂志,2017,5(6):417-424.DOI:10.3969/j.issn.2095-5332.2017.06.004.GUO H.Reflections on the pathology evaluation study of donor kidney nephrology of DCD[J/CD].Pract J Organ Transplant(Electr Vers),2017,5(6):417-424.DOI:10.3969/j.issn.2095-5332.2017.06.004.
[8]HAAS M.Donor kidney biopsies:pathology matters,and so does the pathologist[J].Kidney Int,2014,85(5):1016-1019.DOI:10.1038/ki.2013.439.
[9]GOUMENOS DS,KALLIAKMANI P,TSAMANDASAC,et al.The prognostic value of frozen section preimplantation graft biopsy in the outcome of renal transplantation[J].Ren Fail,2010,32(4):434-439.DOI:10.3109/08860221003658241.
[10]RANDHAWA P.Role of donor kidney biopsies in renal transplantation[J].Transplantation,2001,71(10):1361-1365.
[11]RANDHAWA PS,MINERVINI MI,LOMBARDERO M,et al.Biopsy of marginal donor kidneys:correlation of histologic findings with graft dysfunction[J].Transplantation,2000,69(7):1352-1357.
[12]REMUZZI G,GRINYòJ,RUGGENENTI P,et al.Early experience with dual kidney transplantation in adults using expanded donor criteria.Double Kidney Transplant Group(DKG)[J].J Am Soc Nephrol,1999,10(12):2591-2598.
[13]ISONIEMI H,TASKINEN E,H?YRY P.Histological chronic allograft damage index accurately predicts chronic renal allograft rejection[J].Transplantation,1994,58(11):1195-1198.
[14]KARPINSKI J,LAJOIE G,CATTRAN D,et al.Outcome of kidney transplantation from high-risk donors is determined by both structure and function[J].Transplantation,1999,67(8):1162-1167.
[15]MUNIVENKATAPPA RB,SCHWEITZER EJ,PAPADIMITRIOUJC,et al.The Maryland aggregate pathology index:a deceased donor kidney biopsy scoring system for predicting graft failure[J].Am J Transplant,2008,8(11):2316-2324.DOI:10.1111/j.1600-6143.2008.02370.x.
[16]FLECHNER SM,CAMPBELL SC.The use of kidneys with small renal tumors for transplantation:who is taking the risk?[J].Am J Transplant,2012,12(1):48-54.DOI:10.1111/j.1600-6143.2011.03794.x.
[17]HAAS M,LOUPY A,LEFAUCHEUR C,et al.The Banff 2017 Kidney Meeting report:revised diagnostic criteria for chronic active T cell-mediated rejection,antibody-mediated rejection,and prospects for integrative endpoints for next-generation clinical trials[J].Am JTransplant,2018,18(2):293-307.DOI:10.1111/ajt.14625.
[18]HUANG G,WU LW,YANG SC,et al.Factors influencing graft outcomes following diagnosis of polyomavirus-associated nephropathy after renal transplantation[J].PLo S One,2015,10(11):e0142460.DOI:10.1371/journal.pone.0142460.
[19]HUANG G,CHEN LZ,QIU J,et al.Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China:a single-center analysis of incidence,reduction in immunosuppression and clinical course[J].Clin Transplant,2010,24(5):599-609.DOI:10.1111/j.1399-0012.2009.01141.x.
[20]KOTTON CN,KUMAR D,CALIENDO AM,et al.The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J].Transplantation,2018,102(6):900-931.DOI:10.1097/TP.0000000000002191.
[21]TILLOU X,GULERYUZ K,COLLON S,et al.Renal cell carcinoma in functional renal graft:toward ablative treatments[J].Transplant Rev(Orlando),2016,30(1):20-26.DOI:10.1016/j.trre.2015.07.001.
[22]SCOTT MH,SELLS RA.Primary adenocarcinoma in a transplanted cadaveric kidney[J].Transplantation,1988,46(1):157-158.
[23]TILLOU X,DOERFLER A,COLLON S,et al.De novo kidney graft tumors:results from a multicentric retrospective national study[J].Am J Transplant,2012,12(12):3308-3315.DOI:10.1111/j.1600-6143.2012.04248.x.
[24]NALESNIK MA,WOODLE ES,DIMAIO JM,et al.Donor-transmitted malignancies in organ transplantation:assessment of clinical risk[J].Am J Transplant,2011,11(6):1140-1147.DOI:10.1111/j.1600-6143.2011.03565.x.